Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHarbourVest Private Equity Regulatory News (HVPE)

Share Price Information for HarbourVest Private Equity (HVPE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,410.00
Bid: 2,405.00
Ask: 2,430.00
Change: 0.00 (0.00%)
Spread: 25.00 (1.04%)
Open: 2,410.00
High: 0.00
Low: 0.00
Prev. Close: 2,410.00
HVPE Live PriceLast checked at -
HarbourVest Global Private Equity is an Investment Trust

To generate superior shareholder returns through long-term capital appreciation by investing primarily in a diversified portfolio of private market investments.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison reviews HarbourVest Global Private Equity

23 May 2019 14:58

RNS Number : 0355A
HarbourVest Global Priv. Equity Ltd
23 May 2019
 

 

London, UK, 23 May 2019

Edison reviews HarbourVest Global Private Equity (HVPE/HVPD)

HarbourVest Global Private Equity (HVPE) has recorded an uplift in NAV since end-July 2018 of 4.9% and 5.6% in US dollar and sterling terms respectively, with limited impact from increased public market volatility of Q418. Following successful realizations, HVPE aims to rebuild its exposure to the primary strategy (44% vs target 55%), and to the US market (55% vs 65%). Moreover, HVPE looks at further diversification through investments in real assets which are characterized by low correlation with equity markets and provide stable cash flows. Following the transaction in February 2019, HVPE's exposure to real asset and mezzanine investments now stands at 14% (at end-April 2019).

 

HVPE's share price discount to NAV widened temporarily to 28% in December as its shares followed the broader market sell-off, but subsequently narrowed to c 15% as the share price rebounded while NAV remained broadly stable. This suggests that HVPE's shares tend to overreact in response to general market developments, which may temporarily result in a wider discount to NAV.

Click here to view the full report.

 

All reports published by Edison are available to download free of charge from its website

www.edisongroup.com

About Edison: Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information please contact Edison:

Milosz Papst, +44 (0)20 3077 5700

Gavin Wood, +44 (0)20 3681 2503

Investmenttrusts@edisongroup.com

 

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn https://www.linkedin.com/company/edison-investment-research 

Twitter www.twitter.com/Edison_Inv_Res 

YouTube www.youtube.com/edisonitv 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRABXGDUUUDBGCX
Date   Source Headline
23rd Sep 20227:00 amRNSTransaction in Own Shares
21st Sep 20227:00 amRNSTransaction in Own Shares
20th Sep 20228:39 amRNSNet Asset Value(s)
19th Aug 20227:00 amRNSNet Asset Value(s)
16th Aug 20227:00 amRNSIncrease to Credit Facility
2nd Aug 20227:00 amRNSDirector Declaration
21st Jul 20227:00 amRNSNet Asset Value(s)
20th Jul 20223:51 pmRNSResult of AGM
23rd Jun 20223:37 pmRNSDirector/PDMR Shareholding
22nd Jun 20227:00 amRNSNet Asset Value(s)
20th Jun 20227:00 amRNSNotice of AGM
27th May 202210:17 amRNSHVPE To Publish Annual Results Presentation
27th May 20227:00 amRNSAnnual Financial Report
20th May 20223:17 pmRNSMello Investor Conference
20th May 20227:00 amRNSAppointment of Director
19th May 20227:00 amRNSNet Asset Value(s)
16th May 20227:00 amRNSAppointment of Joint Corporate Broker
13th May 20223:36 pmRNSNotice of Annual Results
25th Apr 20227:00 amRNSNet Asset Value(s)
19th Apr 20224:04 pmRNSNet Asset Value(s)
18th Mar 20227:00 amRNSNet Asset Value(s)
8th Mar 20229:35 amRNSHolding(s) in Company
22nd Feb 20225:06 pmRNSHolding(s) in Company
21st Feb 20223:31 pmRNSHolding(s) in Company
18th Feb 20227:00 amRNSNet Asset Value(s)
19th Jan 20227:00 amRNSNet Asset Value(s)
21st Dec 20217:00 amRNSStatement re Credit Facility Increase
20th Dec 20217:00 amRNSNet Asset Value(s)
19th Nov 20217:00 amRNSNet Asset Value(s)
3rd Nov 202110:03 amRNSDirector/PDMR Shareholding
28th Oct 20217:00 amRNSHalf-year Report
19th Oct 20217:00 amRNSNet Asset Value(s)
12th Oct 20212:51 pmRNSHolding(s) in Company
12th Oct 20217:00 amRNSNotice of Results
7th Oct 202110:10 amRNSDirector Declaration
27th Sep 20219:14 amRNSHolding(s) in Company
21st Sep 20219:59 amRNSHolding(s) in Company
21st Sep 20217:00 amRNSNet Asset Value(s)
15th Sep 20219:34 amRNSNet Asset Value(s)
19th Aug 20217:00 amRNSNet Asset Value(s)
16th Aug 20212:52 pmRNSHolding(s) in Company
29th Jul 202110:17 amRNSDirector/PDMR Shareholding
21st Jul 20213:48 pmRNSResult of AGM
21st Jul 20217:00 amRNSNet Asset Value(s)
6th Jul 20213:01 pmRNSHolding(s) in Company
23rd Jun 20217:00 amRNSNet Asset Value(s)
21st Jun 20214:32 pmRNSNotice of Annual General Meeting
28th May 20217:00 amRNSAnnual Financial Report
21st May 20217:00 amRNSNet Asset Value(s)
19th May 20213:05 pmRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.